Portland, OR, Aug. 14, 2019 (GLOBE NEWSWIRE) -- According to the report by Allied Market Research, the global Ophthalmic Viscoelastic Devices Market generated $2.33 billion in 2018 and is estimated to reach $3.22 billion by 2026, growing at a CAGR of 4.1% from 2019 to 2026. The report offers an extensive analysis of drivers & opportunities, changing market dynamics, competitive market scenario, key segments, and market size & projections.
Request Report Sample at https://www.alliedmarketresearch.com/request-sample/5357
Increase in prevalence of cataract & glaucoma across the world, rise in the number of government initiatives to control visual impairment, and a surge in the number of ophthalmic surgeries drive the growth in the market. On the other hand, unavailability of advanced eye surgery devices & ophthalmic clinics hinders the growth. Contrarily, untapped potential of the emerging economies would create new opportunities in the industry.
The cohesive ophthalmic viscoelastic segment to offer lucrative opportunities:
Based on product, the cohesive ophthalmic viscoelastic segment held the major share, contributing more than two-thirds of the total share in 2018 and is estimated to maintain its dominance during the forecast period. This segment is estimated to register the highest growth rate, with a CAGR of 4.3% from 2019 to 2026. This is due to the wide array of benefits offered in cataract surgery such as creation & maintenance of space in the anterior segment of the eye and implantation & reduction of the deleterious vector. The research also analyzes the dispersive ophthalmic viscoelastic segment.
The hospital's segment to maintain dominance by 2026:
Based on end-user, the hospital's segment generated the highest revenue in 2018, accounting for more than half of the total market share. This is due to the availability of expensive eye surgical devices in hospitals. However, the ophthalmic clinic's segment would register the highest CAGR of 5.0% from 2019 to 2026.
North America to lead throughout the study period:
Based on geography, North America accounted for more than two-fifths of the total share in 2018 and is expected to maintain its leadership status throughout the forecast period. Simultaneously, the Asia-Pacific region would register the fastest CAGR of 5.5% from 2019 to 2026.
Do Purchase Enquiry at https://www.alliedmarketresearch.com/purchase-enquiry/5357
Leading players in the industry:
The leading market players analyzed in the report include Eyekon Medical Inc., Cima Technology Inc., Carl Zeiss Meditec AG, Altacor Haohai Biological Technology, Johnson & Johnson, Bohus Biotech Ab, Bausch Health Companies, Inc., Novartis International AG (Alcon Inc.), and Rumex International Corporation.
About Us:
Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.